Valuation : FONAR Corporation

Market Cap 125M 108M 101M 92.5M 173M 11.81B 174M 1.2B 464M 6.06B 470M 459M 19.52B P/E 2024
10.3x
P/E 2025 11.9x
Enterprise Value 108M 92.53M 87.06M 79.53M 149M 10.15B 149M 1.03B 399M 5.21B 404M 395M 16.78B EV / Sales 2024
0.9x
EV / Sales 2025 0.77x
Free-Float
76.43%
Yield 2024 *
-
Yield 2025 -
1 day-0.10%
6 months+2.80%
Current year+2.86%
Current year 18.3
Extreme 18.3
19.16
1 year 13.9
Extreme 13.9
19.16
3 years 12
Extreme 12
24.05
5 years 12
Extreme 12
24.05
10 years 11
Extreme 11
33.9
Manager TitleAgeSince
Chief Executive Officer 61 10/02/2016
Director of Finance/CFO 71 31/08/2022
Investor Relations Contact - 31/05/1978
Director TitleAgeSince
Chairman 61 06/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
03/06/26 Other

Chief Executive Officer

0 0%
03/06/26 Other

Chief Financial Officer

0 0%
03/06/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-.--%+22.37%+17.48% 125M
-0.75%-1.35%+24.60%+13.24% 227B
-1.60%-3.89%+3.72%-20.39% 146B
-0.85%-1.58%-21.45%+19.18% 130B
+1.81%+2.05%-55.42%-10.32% 69.27B
+0.13%-0.34%+11.07%+18.34% 51.82B
+0.49%-1.32%-17.44%-13.87% 50.45B
+0.59%-1.94%+17.17%+27.06% 42.53B
-1.01%-1.28%+33.64%+48.14% 40.22B
-1.55%+1.22%+120.58%+36.88% 32.95B
Average -0.28%-1.31%+13.88%+13.57% 78.98B
Weighted average by Cap. -0.54%-1.55%+6.66%+8.04%

Financials

2024 2025
Net sales 103M 88.53M 83.3M 76.09M 142M 9.71B 143M 984M 382M 4.98B 386M 378M 16.06B 104M 89.79M 84.48M 77.18M 144M 9.85B 145M 998M 387M 5.05B 392M 383M 16.28B
Net income 10.57M 9.09M 8.56M 7.82M 14.62M 998M 14.66M 101M 39.23M 512M 39.68M 38.82M 1.65B 8.33M 7.17M 6.75M 6.16M 11.53M 787M 11.56M 79.73M 30.94M 404M 31.3M 30.61M 1.3B
Net Debt -14.8M -12.74M -11.98M -10.95M -20.48M -1.4B -20.53M -142M -54.95M -717M -55.58M -54.37M -2.31B -17.54M -15.09M -14.2M -12.97M -24.26M -1.66B -24.33M -168M -65.1M -849M -65.85M -64.41M -2.74B
Logo FONAR Corporation
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Employees
535
  1. Stock Market
  2. Stocks
  3. FONR Stock